May 30, 2015
Article
Albert Einstein College of Medicine researchers have developed a new vaccine type that shows promise to possibly become the first ever for preventing genital herpes.
American researchers suggest that households can serve as long-term reservoirs for USA300, a virulent and easily transmissible strain of methicillin-resistant Staphylococus aureus (MRSA) and the predominant community-associated MRSA clone in the United States.
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot
Estrogen Treatment Reduces Risk of COVID-19 Mortality
FDA Approves Pfizer-BioNTech Booster Shot for Children 5 and Older
An Issue About COVID-19